CLDN18 and hepatocellular carcinoma: In contrast, METTL7B, CLDN18, SOCS3, RANSE3 and ITGA9 were overexpressed in BCLC Stage D, and showed significant differences compared to each of the other stages, indicating a possible prognostic role in HCC (Fig. 2A, C, E, H and I).